Trigeminal Nerve Stimulation: A Recently Approved Treatment Approach in Attention Deficit Hyperactivity Disorder
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nd/3.0/us/Tarih
2021Üst veri
Tüm öğe kaydını gösterKünye
Çöpür, M., & Çöpür, S. (2021). Trigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57(1), 1-3.Özet
Attention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications include methylphenidate, atomoxetine, and amphetamines while trigeminal nerve stimulator (TNS) is the first medical device in ADHD with FDA approval. The aim of this article is to evaluate the latest studies in this field.
Kaynak
Egyptian Journal of Neurology Psychiatry and NeurosurgeryCilt
57Sayı
1Koleksiyonlar
Aşağıdaki lisans dosyası bu öğe ile ilişkilidir: